Abstract
Magnetic resonance spectroscopy can provide noninvasive metabolite profiles of childhood brain tumors and these are highly characteristic for tumor type. This information is increasingly being used to provide a noninvasive diagnostic aid but since tumor pathologies differ in children to adults, child specific classifiers are required. Despite the strong dependence of the MRS metabolite profile on tumor type, some metabolites are also biomarkers of prognosis both within and across tumor groups. Some evidence is also emerging that MRS can also provide biomarkers of treatment response where prior to changes on conventional MRI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Farmer JP, Montes JL, Freeman CR, Meagher-Villemure K, Bond MC, O’Gorman AM. Brainstem Gliomas. A 10-year institutional review. Pediatr Neurosurg. 2001;34(4):206–14.
Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys. 1998;40(2):265–71.
Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, Kovnar E, Burger P, Sanford RA, Kepner J, Friedman H, Kun LE. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;43(5):959–64.
Pan E, Prados M. Brainstem Gliomas. In: Gupta N, Haas-Kogen D, Banerjee A, editors. Pediatric CNS tumors, vol. 3. Berlin: Springer; 2004. p. 49–61.
Nelson Jr MD, Soni D, Baram TZ. Necrosis in pontine gliomas: radiation induced or natural history? Radiology. 1994;191(1):279–82.
Yoshimura J, Onda K, Tanaka R, Takahashi H. Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases. Neurol Med Chir (Tokyo). 2003;43(8):375–82. discussion 382.
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492–507.
Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007;25(4):867–90. vii.
Sands SA, van Gorp WG, Finlay JL. Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Childs Nerv Syst. 1998;14(10):587–9.
Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, McCowage GB, Diez B, Allen JC, Gopalan A, Cornelius AS, Termuhlen A, Abromowitch M, Sposto R, Finlay JL. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols. Pediatr Blood Cancer. 2008;50(6):1169–75.
Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer. 2008;51(2):235–40.
Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer. 2008;50(2):312–8.
Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer. 2007;49(1):34–40.
Opstad KS, Ladroue C, Bell BA, Griffiths JR, Howe FA. Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification. NMR Biomed. 2007;20(8):763–70.
Huang Y, Lisboa PJG, El-Deredy W. Tumour grading from magnetic resonance spectroscopy: a comparison of feature extraction with variable selection. Stat Med. 2003;22(1):147–64.
Reynolds GM, Peet AC, Arvanitis TN. Generating prior probabilities for classifiers of brain tumours using belief networks. BMC Med Inform Decis Mak. 2007;7:27.
Davies NP, Wilson M, Harris LM, Natarajan K, Lateef S, Macpherson L, Sgouros S, Grundy RG, Arvanitis TN, Peet AC. Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. NMR Biomed. 2008;21(8):908–18.
Ackerstaff E, Glunde K, Bhujwalla ZM. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem. 2003;90(3):525–33.
Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999;12(7):413–39.
Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball Jr WS. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol. 1998;19(3):535–40.
Panigrahy A, Krieger MD, Gonzalez-Gomez I, Liu X, McComb JG, Finlay JL, Nelson Jr MD, Gilles FH, Bluml S. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol. 2006;27(3):560–72.
Negendank W, Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticancer Res. 1996;16(3B):1533–8.
Barker PB. Fundamentals of MR spectroscopy. In: Gillard JH, Waldman AD, Barker PB, editors. Clinical MR neuroimaging—diffusion, perfusion and spectroscopy. Cambridge: Cambridge University Press; 2005. p. 15–20.
Panigrahy A, Nelson MJ, Blüml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol. 2010;40(1):3–30.
Martínez-Bisbal MC, Celda B. Proton magnetic resonance spectroscopy imaging in the study of human brain cancer. Q J Nucl Med Mol Imaging. 2009;53(6):618–30.
McRobbie DW. It’s not just squiggles: in vivo spectroscopy. In: McRobbie DW, Moore EA, Graves MJ, Prince MR, editors. MRI From Picture to Proton; 2008. p 306–324.
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672–9.
Wilson M, Reynolds G, Kauppinen RA, Arvanitis TN, Peet AC. A constrained least-squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data. Magn Reson Med. 2011;65(1):1–12.
Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12(2–3):141–52.
Wilson M, Davies NP, Sun Y, Natarajan K, Arvanitis TN, Kauppinen RA, Peet AC. A comparison between simulated and experimental basis sets for assessing short-TE in vivo 1H MRS data at 1.5 T. NMR Biomed. 2010;23(10):1117–26.
Moreno-Torres A, Martinez-Perez I, Baquero M, Campistol J, Capdevila A, Arus C, Pujol J. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: Contribution to noninvasive differential diagnosis with cerebellar astrocytomas. Neurosurgery. 2004;55:824–9.
Wilke M, Eidenschink A, Muller-Weihrich S, Auer DP. MR diffusion imaging and 1H spectroscopy in a child with medulloblastoma. A case report. Acta Radiol. 2001;42(1):39–42.
Tong Z, Yamaki T, Harada K, Houkin K. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging. 2004;22(5):735–42.
Kovanlikaya A, Panigrahy A, Krieger M, Gonzalez-Gomez I, Ghugre N, McComb J, Gilles F, Nelson M, Blüml S. Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. Radiology. 2005;236(3):1020–5.
Ashok P, Finlay JL, Nelson MD, Gilles FH, Gonzalez-Gomez I, Krieger MD, Bluml S. In vivo MR spectroscopy and diffusion MR imaging of the desmoplastic subtype of medulloblastoma. Dallas, Texas, US: Society of Neuro-Oncology; 2007.
Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol. 1995;16(9):1821–33.
Harris LM, Davies NP, Macpherson L, Lateef S, Natarajan K, Brundler MA, Sgouros S, English MW, Arvanitis TN, Grundy RG, Peet AC. Magnetic resonance spectroscopy in the assessment of pilocytic astrocytomas. Eur J Cancer. 2008;44(17):2640–7.
Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery. 1993;33(6):1026–9. discussion 1029–1030.
Jallo GI, Biser-Rohrbaugh A, Freed D. Brainstem gliomas. Childs Nerv Syst. 2004;20(3):143–53.
Barkovich AJ, Krischer J, Kun LE, Packer R, Zimmerman RA, Freeman CR, Wara WM, Albright L, Allen JC, Hoffman HJ. Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg. 1990;16(2):73–83.
Seymour ZA, Panigrahy A, Finlay JL, Nelson Jr MD, Bluml S. Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol. 2008;29(5):1006–11.
Panigrahy A, Nelson Jr MD, Finlay JL, Sposto R, Krieger MD, Gilles FH, Bluml S. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol. 2008;10(1):32–44.
Harris LM, Davies N, MacPherson L, Wilson S, English M, Brundler M-A, Arvanitis TN, Grundy R, Peet AC. Short echo time single voxel 1H Magnetic Resonance Spectroscopy in the diagnosis and characterisation of pineal region tumours. Pediatric Blood Cancer. 2011;57(6):972–7.
Brown WD, Gilles FH, Tavare CJ, Rorke LB, Davis RL, Adelman L, Hedley-Whyte ET, Leviton A. Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors. J Neuropathol Exp Neurol. 1998;57(11):1035–40.
Gilles FH, Leviton A, Tavare CJ, Adelman L, Rorke LB, Sobel EL, Hedley-Whyte ET, Davis RL. Definitive classes of childhood supratentorial neuroglial tumors. The childhood brain tumor consortium. Pediatr Dev Pathol. 2000;3(2):126–39.
Hockel M, Schlenger K, Mitze M, Schaffer U, Vaupel P. Hypoxia and radiation response in human tumors. Semin Radiat Oncol. 1996;6(1):3–9.
Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56(19):4509–15.
Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR. Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin Radiat Oncol. 1996;6(1):59–70.
Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610–22.
Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 2004;6(6):553–63.
Peet AC, Davies NP, Ridley L, Brundler MA, Kombogiorgas D, Lateef S, Natarajan K, Sgouros S, Macpherson L, Grundy RG. Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma. Eur J Cancer. 2007;43(6):1037–44.
Broniscer A, Baker SJ, West AN, Fraser MM, Proko E, Kocak M, Dalton J, Zambetti GP, Ellison DW, Kun LE, Gajjar A, Gilbertson RJ, Fuller CE. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol. 2007;25(6):682–9.
Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol. 2000;21(9):1645–9.
Tzika AA, Vigneron DB, Dunn RS, Nelson SJ, Ball Jr WS. Intracranial tumors in children: small single-voxel proton MR spectroscopy using short- and long-echo sequences. Neuroradiology. 1996;38(3):254–63.
Negendank WG. Studies of human tumors by MRS: a review. NMR Biomed. 1992;5:303–24.
Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg. 1996;84(3):449–58.
Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed. 1999;12:123–38.
Sijens PE, Knopp MV, Brunetti A, Wicklow K, Alfano B, Bachert P, Sanders JA, Stillman AE, Kett H, Sauter R, et al. 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med. 1995;33(6):818–26.
Taylor JS, Ogg RJ, Langston JW. Proton MR spectroscopy of pediatric brain tumors. Neuroimaging Clin N Am. 1998;8(4):753–79.
Taylor JS, Langston JW, Reddick WE, Kingsley PB, Ogg RJ, Pui MH, Kun LE, Jenkins JJ, Chen G, Ochs JJ, Sanford RA, Heideman RL. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys. 1996;36(5):1251–61.
Shimizu H, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, Sato K, Arai N, Fujiwara S, Yoshimoto T. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol. 1996;17:737–47.
Chang YW, Yoon HK, Shin HJ, Roh HG, Cho JM. MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy. Pediatr Radiol. 2003;33(12):836–42.
Blüml S, Panigrahy A, Laskov M, Dhall G, Krieger MD, Nelson Jr MD, Finlay JL, Gilles FH. Elevated citrate in pediatric astrocytomas with malignant progression. Neuro-Oncol. 2011;12(10):1107–17.
Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7(3):241–8.
Porto L, Kieslich M, Franz K, Lehrbecher T, Vlaho S, Pilatus U, Hattingen E. Spectroscopy of untreated pilocytic astrocytomas: do children and adults share some metabolic features in addition to their morphologic similarities? Childs Nerv Syst. 2010;26(6):801–6.
Davies NP, Wilson M, Natarajan K, Sun Y, Macpherson L, Brundler MA, Arvanitis TN, Grundy RG, Peet AC. Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo (1)H MRS at 1.5 Tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR. NMR Biomed. 2009;23(1):80–7.
Astrakas LG, Zurakowski D, Tzika AA, Zarifi MK, Anthony DC, De Girolami U, Tarbell NJ, Black PM. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res. 2004;10(24):8220–8.
Marcus KJ, Astrakas LG, Zurakowski D, Zarifi MK, Mintzopoulos D, Poussaint TY, Anthony DC, De Girolami U, Black PM, Tarbell NJ, Tzika AA. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol. 2007;30(3):651–7.
Lazareff JA, Gupta RK, Alger J. Variation of post-treatment H-MRSI choline intensity in pediatric gliomas. J Neurooncol. 1999;41(3):291–8.
Warren KE, Frank JA, Black JL, Hill RS, Duyn JH, Aikin AA, Lewis BK, Adamson PC, Balis FM. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J Clin Oncol. 2000;18(5):1020–6.
Tzika AA, Astrakas LG, Zarifi MK, Zurakowski D, Poussaint TY, Goumnerova L, Tarbell NJ, Black PM. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer. 2004;100(6):1246–56.
Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, Chang S, Prados MD, Sneed PK, Larson DA, Wara WM, McDermott M, Dillon WP, Gutin PH, Vigneron DB. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 1997;87(4):525–34.
Preul MC, Leblanc R, Caramanos Z, Kasrai R, Narayanan S, Arnold DL. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases. Can J Neurol Sci. 1998;25(1):13–22.
Isobe T, Matsumura A, Anno I, Nagatomo Y, Yoshizawa T, Itai Y, Nose T. Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds. No Shinkei Geka. 2003;31(2):167–72.
Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol. 2001;22(7):1316–24.
Weybright P, Sundgren PC, Maly P, Hassan DG, Nan B, Rohrer S, Junck L. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. Am J Roentgenol. 2005;185(6):1471–6.
Smith EA, Carlos RC, Junck LR, Tsien CI, Elias A, Sundgren PC. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions. Am J Roentgenol. 2009;192(2):W45–52.
Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 1997–2001. 2004.
Warren K. Molecularly targeted therapy for pediatric brain tumors. J Neurooncol. 2005;75(3):335–43.
Acknowledgments
CRUK and EPSRC Cancer Imaging Programme at the Children’s Cancer and Leukaemia Group (CCLG) in association with the MRC and Department of Health (England) (C7809/A10342).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gill, S.K., Panigrahy, A., Arvanitis, T.N., Peet, A.C. (2013). Magnetic Resonance Spectroscopy of Pediatric Brain Tumors. In: Blüml, S., Panigrahy, A. (eds) MR Spectroscopy of Pediatric Brain Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5864-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5864-8_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5863-1
Online ISBN: 978-1-4419-5864-8
eBook Packages: MedicineMedicine (R0)